Close

Professor Andrew Briggs

BSc (Hons) MSc DPhil

Professor

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Professor of Health Economics at the London School of Hygiene & Tropical Medicine, I  previously held the William R Lindsay Chair in Health Economics at the University of Glasgow. Following a sabbatical at Memorial Sloan Kettering Cancer Center, New York in 2016/17, I remain a Visiting Investigator, collaborating with Dr Peter Bach on value frameworks for oncology medications.

I have  co-authored two textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and the other published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

A link to my GooGle Scholar page: https://bit.ly/GS-briggs

Affiliations

Faculty of Public Health and Policy
Department of Health Services Research and Policy

Centres

Centre for Evaluation
Centre for Statistical Methodology

Teaching

Our highly successful Foundations and Advanced Decision Modelling for Health Economic Evaluation courses have been developed for online delivery and include, as a new element for 2021, the ability to follow the practical exercises in the statistical package R as well as in Excel.

For full details and to book a place on the upcoming courses in May and June 2021, please visit the course website.

Research

My main methodological focus of research has been health economic evaluation, particularly statistical methods for cost-effectiveness analysis.  This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials.  I have a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness analysis.

Research Area
Decision analysis
Economic evaluation
Randomised controlled trials
Discipline
Health economics
Country
United Kingdom
United States of America
South Africa
Region
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data.
Briggs A; Nasser S; Hammerby E; Buchs S; Virchow JC
2021
Journal of patient-reported outcomes
Mendelian randomization: estimation of inpatient hospital costs attributable to obesity.
Dick K; Schneider JE; Briggs A; Lecomte P; Regnier SA; Lean M
2021
Health economics review
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies.
Gaultney JG; Bouvy JC; Chapman RH; Upton AJ; Kowal S; Bokemeyer C; Solà-Morales O; Wolf J; Briggs AH
2021
Applied health economics and health policy
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis.
Hanna CR; Robles-Zurita JA; Briggs A; Harkin A; Kelly C; McQueen J; Allan K; Pearson S; Hollander H; Glimelius B
2021
Clinical colorectal cancer
Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial.
Heggie R; Briggs A; Stanley B; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M
2021
International journal of cardiology
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19.
Briggs AH; Goldstein DA; Kirwin E; Meacock R; Pandya A; Vanness DJ; Wisløff T
2020
Health economics
See more Publications